
A diabetes drug has been authorised to help obese and overweight adults with weight management and loss, according to the Medicines and Healthcare products Regulatory Agency (MHRA).
Such patients with weight-related health problems – such as prediabetes, high blood pressure, high cholesterol or heart problems – could have access to Tirzepatide if it receives further approval from the National Institute for Health and Care Excellence (Nice).